Large-Cell Neuroendocrine Carcinoma of the Lung: An Aggressive Neuroendocrine Lung Cancer

Seminars in Thoracic and Cardiovascular Surgery

Volumn 18, Issue 3, 2006, Pages 206-210

  Fernandez, Felix G ^a   Battafarano, Richard J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

large cell neuroendocrine carcinoma; neuroendocrine spectrum; non small cell lung cancer; pulmonary tumors

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; OCTREOTIDE;

ADJUVANT THERAPY; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HUMAN; LARGE CELL CARCINOMA; LONG TERM CARE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; METASTASIS; MOLECULAR BIOLOGY; NEUROENDOCRINE TUMOR; PROGNOSIS; SURVIVAL RATE;

CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33845506834     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2006.08.007     Document Type: Article

References (34)

1. Arrigoni M.G., Woolner L.B., and Bernatz P.E. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64 3 (1972) 413-421
2. Gould V.E., and Chefec G. Ultrastructure and biochemical analysis of "undifferentiated" pulmonary carcinomas. Hum Pathol 9 (1978) 377
3. Gould V.E., Linnoila R.I., Memoli V.A., et al. E. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab Invest 49 (1983) 519-537
4. Travis W.D., Linnoila R.I., Tsokos M.G., et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15 6 (1991) 529-553
5. Travis W.D., Rush W., Flieder D.B., et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22 8 (1998) 934-944
6. Dresler C.M., Ritter J.H., Patterson G.A., et al. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 63 1 (1997) 180-185
7. World Health Organization. Histologic typing of lung and pleural tumors. (ed 3) (1999), The Organization, Geneva
8. Wick M.R., Berg L.C., and Hertz M.I. Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors. Am J Clin Pathol 97 6 (1992) 796-805
9. Takei H., Asamura H., Maeshima A., et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124 2 (2002) 285-292
10. Rusch V.W., Klimstra D.S., and Venkatraman E.S. Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 62 3 (1996) 798-809 discussion 809-810
11. Przygodzki R.M., Finkelstein S.D., Langer J.C., et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 148 5 (1996) 1531-1541
12. Ab' Saber A.M., Neto L.M.M., Bianchi C.P., et al. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas. Ann Thorac Surg 77 (2004) 1883-1890
13. Iyoda A., Hiroshima K., Moriya Y., et al. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity. Ann Thorac Surg 77 (2004) 1891-1895
14. Battafarano R.J., Lewis J.S., Ritter J., et al. Gene expression profiling distinguishes large cell lung cancer with disparate clinical outcomes, Abstract #1872. IASLC Meeting (2005)
15. Jiang S.X., Kameya T., Shoji M., et al. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 22 5 (1998) 526-537
16. Iyoda A., Hiroshima K., Toyozaki T., et al. Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology. Cancer 91 11 (2001) 1992-2000
17. Paci M., Cavazza A., Annessi V., et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 77 4 (2004) 1163-1167
18. Battafarano R.J., Fernandez F.G., Ritter J., et al. Large cell neuroendorine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg 130 1 (2005) 166-172
19. Garcia-Yuste M., Matilla J.M., Alvarez-Gago T., et al. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Ann Thorac Surg 70 1 (2000) 258-263
20. Asamura H., Kameya T., Matsuno Y., et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24 1 (2006) 70-76
21. Doddoli C., Barlesi F., Chetaille B., et al. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg 77 4 (2004) 1168-1172
22. Zacharias J., Nicholson A.G., Ladas G.P., et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 75 2 (2003) 348-352
23. Papotti M., Croce S., Bello M., et al. Expression of somatostatin receptor types 2, 3, and 5 in biopsies and specimens of human lung tumours. Virchows Arch 439 (2001) 787-797
24. Kwekkeboom D.J., Kho G.S., Lamberts S.W., et al. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 21 (1994) 1106-1113
25. Musi M., Carbone R.G., Bertocchi C., et al. Bronchial carcinoid tumors: a study on clinicopathologic features and role of octreotide scintigraphy. Lung Cancer 22 (1998) 97-102
26. Filosso P.L., Ruffini E., Oliaro A., et al. Long term survival of atypical bronchial carcinoid with liver metastases, treated with octreotide. Eur J Cardiothorac Surg 21 (2002) 913-917
27. Battafarano R.J., Piccirillo J.F., Meyers B.F., et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 127 2 (2002) 280-287
28. Cooper W.A., Thourani V.H., Gal A.A., et al. The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 119 1 (2001) 14-148
29. Linnoila R.I., Piantadosi S., and Ruckdeschel J.C. Impact of neuroendocrine differentiation on non-small cell lung cancer. Chest 106 suppl (1994) 367S-371S
30. Travis W.D., Gal A.A., Colby T.V., et al. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 29 3 (1998) 272-279
31. Hage R., Seldenrijk K., de Bruin P., et al. Pulmonary large-cell neuroendocrine carcinoma (LCNEC). Eur J Cardiothorac Surg 23 4 (2003) 457-460
32. Iyoda A., Hiroshima K., Toyozaki T., et al. Adjuvant chemotherapy for large cell carcinoma with neuroendocrine features. Cancer 92 5 (2001) 1108-1112
33. Lai S.-L., Goldstein L.J., Gottesman M.M., et al. MDR1 gene expression in lung cancer. J Natl Cancer Inst 81 (1989) 1144-1150
34. O'Byrne K.J., Schally A.V., Thomas A., et al. Somatostatin, its receptors and analogs, in lung cancer. Chemotherapy 47 (2001) 78-108